Preliminary Report of Partial-breast Irradiation Following Neoadjuvant Chemotherapy from COMBAT-NEO: Clinical Outcome of Multicatheter BrAchyTherapy after NEOadjuvant Chemotherapy
محل انتشار: فصلنامه سرطان پستان، دوره: 8، شماره: 2
سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 94
فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_ARCHB-8-2_014
تاریخ نمایه سازی: 9 آبان 1401
چکیده مقاله:
Background: Breast-conserving therapy (BCT) with partial-breast irradiation(PBI) has become a standard alternative to whole-breast irradiation. Recently,neoadjuvant chemotherapy (NACT) has been widely performed for early breastcancer. Although BCT using perioperative PBI decreased invasiveness andgeographic miss, risks of adverse events and local recurrence remain a concern forpatients receiving NACT. Thus, a prospectively registered study, the ClinicalOutcome of Multicatheter BrAchyTherapy after NEOadjuvant chemotherapy(COMBAT-NEO), was conducted.Methods: Patients who underwent BCT using multicatheter-interstitialbrachytherapy (MIB) by intraoperative catheter implant were analyzed. Early andlate adverse events (AEs) including higher grade skin toxicities and woundcomplications, and tumor control of patients receiving NACT were evaluated incomparison with adjuvant chemotherapy (ACT) and no chemotherapy (no-CT).Results: Between April ۲۰۱۷ and February ۲۰۲۰, ۲۶۵ consecutive patients whoreceived single-stage BCT were evaluated, including ۱۳ NACT (۴.۹%), ۶۸ ACT(۲۵.۷%), and ۱۸۴ no-CT (۶۹.۴%). The median follow-up time and age were ۳۰.۰months and ۵۹.۰ years, respectively. All patients were followed up for at least ۱۲months. Although AEs in NACT, ACT, and no-CT were observed in ۱ (۷.۷%), ۵(۷.۴%), and ۱۱ (۶.۰%) patients, respectively (p = ۰.۹۱) and there was no acute AE inNACT patients. Overall, ۳ (۱.۱%) ipsilateral and ۱ (۰.۴%) contralateral breast tumorrecurrences were observed in no-CT patients. There were no regional and distantrecurrences.Conclusion: Although this pilot study was based on a small sample size withshort follow-up, these preliminary results support the study of a single-stage BCTwith MIB-PBI following NACT.
کلیدواژه ها:
نویسندگان
Kazuhiko Sato
Department of Breast Oncology, Tokyo-West Tokushukai Hospital, Tokyo, Japan
Hiromi Fuchikami
Department of Breast Oncology, Tokyo-West Tokushukai Hospital, Tokyo, Japan
Naoko Takeda
Department of Breast Oncology, Tokyo-West Tokushukai Hospital, Tokyo, Japan
Takahiro Shimo
Department of Radiation Oncology, Tokyo-West Tokushukai Hospital, Tokyo, Japan
Masahiro Kato
Department of Radiation Oncology, Tokyo-West Tokushukai Hospital, Tokyo, Japan
Tomohiko Okawa
Preventive Medical Center, Sano City Hospital, Tochigi, Japan